Tag Archives: Arthritis Foundation advocates

biosimilars win in new work

Victory in New York! Biosimilar Legislation Signed Into Law

On behalf of the more than 3.6 million New Yorkers (including 18,400 children) with doctor-diagnosed arthritis, the Arthritis Foundation thanks Governor Andrew Cuomo for signing biosimilar legislation into law. The new law, A.7509/S.4788, enhances patient access to new and innovative medications while ensuring that pharmacists are communicating critical and up-to-date medical information about patients to physicians.

Continue reading Victory in New York! Biosimilar Legislation Signed Into Law

california-advocacy-summit

California Advocates Work for Passage of Bill That Will Improve Continuity of Care When Insurance Carrier Changes

It’s not uncommon for patients to change their insurance carriers. Sometimes it’s by choice, perhaps because they find a carrier that better suits their needs. Other times, it might be out of their control, like when their employment changes. Regardless of why carriers are changed, should patients be required to restart the utilization management process with their new insurance carrier, essentially starting over and potentially undoing years of effective and consistent care? Continue reading California Advocates Work for Passage of Bill That Will Improve Continuity of Care When Insurance Carrier Changes

Arthritis Foundation Advocate Awards

Staci Penner and Graci Diggs Selected for Advocacy & Access High Honors

Staci Penner and Graci Diggs have devoted their voices, stories and wholehearted advocacy efforts to helping the arthritis community live better lives. Today, we celebrate their advocacy efforts by announcing their selection for the Arthritis Foundation’s Edward M. Kennedy Advocacy Leadership Award and Emerging Leader Award, respectively.
Continue reading Staci Penner and Graci Diggs Selected for Advocacy & Access High Honors